Liminal BioSciences Inc. PFSCF

Primary Symbol: LMNL

Healthcare Biotechnology

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.

NDAQ:LMNL - Post by User

Liminal BioSciences Inc.

Bullboard Posts

Post by sollmgon Mar 21, 2019 1:36pm

222 Views

Post# 29518158

Current Short Positions

Current Reported Shares Outstanding 739,130,546

CDN Short Position 5,937,763 (-785,080) 0.8% of Float

US Short Position 7,942,100 (+37,300) 1.08 % of Float

Total Reported Short Positions 13,879,863 1.88 % of Float

Bullboard Posts

Barrick Gold employees detained in Mali amid ongoing dispute